Spero Therapeutics Inc.
0.92
-0.05 (-5.56%)
At close: Jan 15, 2025, 10:26 AM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income 22.81M -46.41M -89.76M -78.28M -60.92M -41.66M -39.89M -32.64M -13.15M
Depreciation & Amortization 367.00K 869.00K 646.00K 761.00K 750.00K 409.00K 363.00K 279.00K 11.00K
Stock-Based Compensation 7.93M 9.12M 9.43M 4.89M 3.78M 2.75M 1.43M 180.00K 21.00K
Other Working Capital -71.14M 22.57M 12.95M -10.42M 6.27M -1.16M -1.91M -148.00K -501.00K
Other Non-Cash Items 6.28M 6.61M 2.37M 513.00K 356.00K -50.00K -1.54M 4.59M 3.52M
Deferred Income Tax n/a n/a 60.00K -362.00K -808.00K n/a 83.00K -580.00K -174.00K
Change in Working Capital -70.38M 22.09M 12.90M -13.39M 6.83M -1.07M 443.00K -792.00K 170.00K
Operating Cash Flow -32.99M -7.73M -64.35M -85.87M -50.02M -39.63M -39.11M -28.96M -9.61M
Capital Expenditures n/a n/a 39.00K -157.00K -314.00K -2.44M -27.00K -830.00K -232.00K
Acquisitions n/a n/a -39.00K -10.63M -29.84M 83.16M -1.18M n/a n/a
Purchase of Investments n/a -26.97M -43.91M -45.72M -88.99M -130.18M n/a n/a n/a
Sales Maturities Of Investments n/a 60.78M 51.55M 56.35M 118.84M 49.45M n/a n/a n/a
Other Investing Acitivies n/a 33.81M 39.00K 10.63M 29.84M -83.16M -27.00K n/a n/a
Investing Cash Flow n/a 33.81M 7.67M 10.47M 29.53M -83.16M -27.00K -830.00K -232.00K
Debt Repayment n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a -54.06M 48.68M 52.22M 350.00K -977.00K 38.36M 34.41M 15.28M
Financial Cash Flow 221.00K -29.55M 84.05M 130.88M 16.14M 69.52M 116.11M 34.41M 15.28M
Net Cash Flow -32.77M -3.48M 27.38M 55.48M -4.35M -53.26M 76.97M 4.62M 5.43M
Free Cash Flow -32.99M -7.73M -64.31M -86.03M -50.33M -42.06M -39.14M -29.79M -9.84M